Clinical trial
Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile…
NCT00462878 · PETHEMA Foundation, Other · Completed
Key facts
| NCT number | NCT00462878 |
|---|---|
| Title | Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation |
| Official title | MERONEM: Observational Study About Efficacy of Meropenem in Comparison of Meropenem and Glycopeptide in Treatment of Neutropenia Febrile in Allogenic Blood Stem Cell Transplantation Patients |
| Acronym | MERONEM |
| Lead sponsor | PETHEMA Foundation, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Allogenic Blood Stem Cell Transplantation, Febrile Neutropenia |
| Intervention type | Drug |
| Interventions | Meropenem, Vancomycin, Teicoplanin |
| Enrollment | 392 |
| Start date | Nov 1, 2002 |
| Completion | Apr 1, 2009 |
| First posted | Apr 19, 2007 |
| Last update posted | May 12, 2009 |
| Countries | Spain |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: